Adele Waugaman, senior digital health coordinator of the COVID-19 response at the United States Agency for International Development (USAID), tells us what the agency focuses on to strength
Demystifying what digital means, empowering people to ‘think digitally’ and acting with confidence are game changing factors for pharma communications according to Katrine Bach, the CEO of
Following an expert webinar discussing the highlights from social media coverage of this year’s American Society of Clinical Oncology Annual Meeting (ASCO 2016), Paul Tunnah muses that pharma n
Pharma companies which embrace social media can reap many benefits beyond marketing, but they must be aware of the regulations and keep within guidelines to avoid heavy penalties.
The venture capital arms of MSD and Amgen have provided $10 million in funding to Culmination Bio, a Utah start-up that aims to build the largest disease-agnostic patient
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio